Announcement on Result of Shareholding Reduction by Shareholder
Filed with SSE · · 4 pages · Chinese
Shanghai Allist Pharmaceuticals Co. Ltd. on 6ix
Earlier from Shanghai Allist Pharmaceuticals
- Indicative Announcement on Change in Equity of Shareholder Reaching 1% Scale
- Announcement on Attending Collective Performance Briefing for Innovative Drug Industry on Semi-annual SSE STAR Market 2025
- Announcement on Implementation of Semi-annual Dividend Distribution for 2025
- Special Report on Semi-annual Deposit and Actual Use of Raised Funds in 2025
- Announcement on Shareholding Reduction Plan for Shareholders
Later from Shanghai Allist Pharmaceuticals
- Report for Q3 2025
- Announcement on Attending Three-Quarter Report Collective Performance Briefing of Listed Companies in Shanghai Jurisdiction in 2025
- Announcement on Completing Term Change and Election of Board of Directors and Appointing Senior Management Members and Securities Affairs Representative
- Announcement on Voluntary Disclosure of the Inclusion of the Company’s Innovative Drugs in the Updated National Medical Insurance Catalog
- Announcement on Using Partial Temporarily Idle Raised Funds for Cash Management
Follow Shanghai Allist Pharmaceuticals into a list and get an email when it puts out news.
Follow Shanghai Allist Pharmaceuticals